Change in body weight and treatment outcome in sputum positive pulmonary tuberculosis patients treated under directly observed treatment short-course
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20182172Keywords:
Weight gain after treatment, Sputum smear grading, Tuberculosis, Adherence to treatmentAbstract
Background: Patients with tuberculosis often suffer from severe weight loss and is used as useful marker to predict TB treatment outcome. Hence a study was planned with an objective to determine the change of patient’s body weight over time throughout treatment and to determine whether there was any association with treatment outcome.
Methods: This was a retrospective cohort study, planned to be conducted among all smear positive pulmonary tuberculosis patients registered in a Tuberculosis Unit of Pune corporation, during the period of January to December 2015. Body weights of patients were recorded from TB treatment cards at the time of diagnosis, after 2 months of intensive phase of treatment and at the end of treatment. Total 344 cases were enrolled. Chi-Square test and Fisher’s exact test and repeated measure ANOVA test was used for analysis.
Results: A bad outcome was more likely among the category II cases as compared to category I, among non-adherent to treatment cases in continuation phase and higher sputum grading at the time of diagnosis i. e. in 3+ sputum smear grading. The weights of the patients at the time of diagnosis, at end of intensive phase and at end of treatment showed statistical significant difference (p<0.0001). The weight gain, more so at end of treatment was significantly associated with good outcome.
Conclusions: Weight gain has prognostic significance in patients with tuberculosis and should be considered as a surrogate marker to monitor response to TB treatment especially in developing countries where extensive laboratory tests are not feasible.
References
WHO. Global Tuberculosis Report, 2016. Available at: www.who.int/tb/publications/global_report/en/. Accessed on 8 March 2017.
Govt. of India. Nutritional care and support for patients with Tuberculosis in India, Central TB Division, Ministry of Health and Family Welfare, New Delhi. Available at: http://www.tbcindia.gov.in. Accessed on 18 April 2017.
More SW, Parande MA, Kamble SW, Kamble MS. Profile of drug-resistant tuberculosis in Western Maharashtra. J Family Med Prim Care. 2017;6:29-33.
Bhargava A. Undernutrition, nutritionally acquired immunodeficiency, and tuberculosis control. BMJ. 2016: 355.
Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & tuberculosis in India: Situation analysis & the way forward. Indian J Med Res. 2016;144(1):11-20.
Van Crevel R, Karyadi E, Netea MG, Verhoef H, Nelwan RH, West CE, et al. Decreased plasma leptin concentrations in Tuberculosis patients are associated with wasting and inflammation. J Clin Endocrinol Metab. 2002;87(2):758-63.
Vasantha M, Gopi PG, Subramani R. Weight gain in patients with tuberculosis treated under Directly Observed Treatment Short-Course (DOTS). Indian J Tuberculosis. 2009;56(1):5-9.
Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi FI, Gillespie SH. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soc Trop Med Hyg. 1996;90:162–6.
World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report, 2009. Available at: www.who.int. Accessed on 30 March 2017.
Hoa NB, Lauritsen JM, Rieder HL. Changes in body weight and tuberculosis treatment outcome in Viet Nam. Int J Tuberc Lung Dis. 2012;17(1):61–6.
Revised National Tuberculosis Control Programme, 2005. Module for Laboratory Technicians. Central TB Division: Directorate General of Health Services, Ministry of Health and Family Welafre, New Delhi, India,22.
WHO, 2013:Definitions and Reporting framework for tuberculosis-2013 revision. Available at: http://www.who.int. Accessed on 22 January 2017.
WHO, 2015. Tuberculosis control in South East Asia region. Annual TB report 2015 Available at: http://www.searo.who.int/tb/annual-tb-report-2015. Accessed on 18 July 2017.
Rohini K, Surekha Bhat, Srikumar PS, Jyoti Saxena, Mahesh Kumar A. Body Weight Gain in Pulmonary Tuberculosis during Chemotherapy. Int J Collaborative Res Internal Med Public Health. 2013;5(4):247-55.
Bernabe-Ortiz A, Carcamo CP, Sanchez JF, Rios J. Weight Variation over Time and Its Association with Tuberculosis Treatment Outcome: A Longitudinal Analysis. PLoS ONE. 2011;6(4):e18474.
Phan MN, Guy ES, Nickson RN, Kao CC. Predictors and patterns of weight gain during treatment for tuberculosis in the United States of America. Int J Infect Dis. 2016;53:1–5.
Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg. 2002;96:291–4.
Krapp F, Véliz JC, Cornejo E, Gotuzzo E, Seas C. Bodyweight gain to predict treatment outcome in patients with pulmonary tuberculosis in Peru. Int J Tuberc Lung Dis. 2008;12(10):1153-9.
How SH, Kuan YC, NG TH, Razali MR, Fuazi AR. Monitoring treatment response in sputum smear positive pulmonary tuberculosis patients: comparison of weight gain, sputum conversion and chest radiograph. Malaysian J Pathol. 2014;36(2):91-6.
Shelke SC, Adhav PS, Moonan PK, Willis M, Parande MA, Satyanarayana S, et al. Photovoice: A Novel Approach to Improving Antituberculosis Treatment Adherence in Pune, India. Hindawi Publishing Corporation Tuberculosis Res Treatment. 2014:302601:4.